Question from Deputy Ken O'Flynn - PQ 52935-26
Deputy O'Flynn asked about the establishment of an interim oversight mechanism pending full rollout of MedLIS and the Regional Laboratory Networks.
- Published date:
- :
Browse and read HSE's latest publications, which include strategic plans, reports, official policies and codes, Parliamentary Question (PQ) responses, and board meeting minutes.
Deputy O'Flynn asked about the establishment of an interim oversight mechanism pending full rollout of MedLIS and the Regional Laboratory Networks.
Deputy Heneghan asked about the introduction of a national transition framework for young people with intellectual disabilities on reaching adulthood.
Deputy O'Flynn asked about the guidance on appropriate intervals for repeat lipid profile testing. Read the HSE response.
Deputy O'Gorman asked for an update on the technical issue which is preventing the issuing of new and renewed European health insurance cards.
Deputy O'Sullivan asked about the number of people who entered treatment for problem nitrous oxide from 2021 to 2025. Read the HSE response.
Deputy Whitmore asked about the number of applicants who have travelled abroad for endometriosis treatment. Read the HSE response.
Deputy Cullinane asked about cancer therapies which are available at the North West Cancer Centre in Altnagelvin that are not reimbursed. Read the HSE response.
Deputy Whitmore asked about the number of applicants who have been approved to travel abroad for endometriosis treatment. Read the HSE response.
Deputy Mitchell asked about the current waiting times for an occupational therapy assessment at the Killester Health Centre. Read the HSE response.
Deputy O'Sullivan asked about the PCRS-approved list of medicines that qualify a patient for the enhanced medicines optimisation support fee.